Skip to Content

Logo 4358 300 (Ranitidine Hydrochloride 300 mg)

Pill with imprint Logo 4358 300 is Beige, Elliptical / Oval and has been identified as Ranitidine Hydrochloride 300 mg. It is supplied by Teva Pharmaceuticals USA.

Ranitidine is used in the treatment of gerd; erosive esophagitis; duodenal ulcer; gastric ulcer maintenance treatment; cutaneous mastocytosis (and more), and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Logo 4358 300

Ranitidine hydrochloride 300 mg Logo 4358 300
Ranitidine hydrochloride 300 mg Logo 4358 300
Ranitidine hydrochloride 300 mg Logo 4358 300

Ranitidine Hydrochloride

Imprint:
Logo 4358 300
Strength:
300 mg
Color:
Beige
Size:
16.00 mm
Shape:
Elliptical / Oval
Availability:
Rx and/or OTC
Drug Class:
H2 antagonists
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Teva Pharmaceuticals USA
Inactive Ingredients:
croscarmellose sodium
hypromelloses
lactose monohydrate
magnesium stearate
microcrystalline cellulose
ferric oxide red
titanium dioxide
triethyl citrate
ferric oxide yellow
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide